Literature DB >> 12663932

Genetic susceptibility to ischemic cerebrovascular disease in Koreans.

Jae-Young Um1, Nyeon-Hyoung An, Sang-Hun Kim, Kang-Min Lee, Yo-Sik Kim, Hyuk Jang, Kwang-Ho Cho, Byung-Soon Moon, Hyung-Min Kim.   

Abstract

Ischemic cerebrovascular disease (ICVD) is a multifactorial disease caused by the interactions of several genetic and environmental factors. Tobacco smoke is a major cause of both cancer and vascular disease. Although its carcinogenic role via induction of DNA damage and mutation is well established, the mechanisms involved in vascular disease remain unclear. One possibility is that DNA damage causes smooth muscle cell proliferation in the intima of arteries, thereby contributing to atherothrombotic processes. The binding of chemicals to DNAis modulated by detoxification enzymes, including glutathione S-transferase (GST). We examined whether polymorphisms in this gene, as well as the angiotensin-converting enzyme (ACE) gene influence the risk of ICVD on smoking status. DNA was analyzed for deletions in the GST M1, T1, and ACE genes by polymerase chain reaction (PCR). No significant association was observed between GST null genotype and ICVD, even in smokers. However, a significant association between ACE and ICVD was observed only in smokers (chi(2) = 0.023, p < 0.05). We conclude that GST polymorphism is not a risk factor for the development of ICVD through smoking and suggest a high probability that ACE polymorphism may contribute to the odds of ICVD in smokers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663932     DOI: 10.1385/JMN:20:1:31

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  29 in total

1.  Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population.

Authors:  M Murata; M Watanabe; M Yamanaka; Y Kubota; H Ito; M Nagao; T Katoh; T Kamataki; J Kawamura; R Yatani; T Shiraishi
Journal:  Cancer Lett       Date:  2001-04-26       Impact factor: 8.679

2.  Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives.

Authors:  K Kario; N Kanai; K Saito; N Nago; T Matsuo; K Shimada
Journal:  Circulation       Date:  1996-05-01       Impact factor: 29.690

Review 3.  Genes for ischaemic stroke: strategies for their detection.

Authors:  P Sharma
Journal:  J Hypertens       Date:  1996-03       Impact factor: 4.844

4.  A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction.

Authors:  N J Samani; J R Thompson; L O'Toole; K Channer; K L Woods
Journal:  Circulation       Date:  1996-08-15       Impact factor: 29.690

5.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

6.  Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks.

Authors:  C L Chen; Q Liu; M V Relling
Journal:  Pharmacogenetics       Date:  1996-04

Review 7.  Glutathione S-transferase: genetics and role in toxicology.

Authors:  R C Strange; P W Jones; A A Fryer
Journal:  Toxicol Lett       Date:  2000-03-15       Impact factor: 4.372

8.  Molecular epidemiology of atherosclerosis.

Authors:  S De Flora; A Izzotti; D Walsh; P Degan; G L Petrilli; J Lewtas
Journal:  FASEB J       Date:  1997-10       Impact factor: 5.191

9.  Arteriosclerotic plaque development is 'promoted' by polynuclear aromatic hydrocarbons.

Authors:  A Penn; C Snyder
Journal:  Carcinogenesis       Date:  1988-12       Impact factor: 4.944

10.  Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism.

Authors:  A H Danser; M A Schalekamp; W A Bax; A M van den Brink; P R Saxena; G A Riegger; H Schunkert
Journal:  Circulation       Date:  1995-09-15       Impact factor: 29.690

View more
  5 in total

1.  Lymphotoxin-alpha gene 252G allelic variant is a risk factor for large-vessel-associated ischemic stroke.

Authors:  Zoltán Szolnoki; Viktória Havasi; Gábor Talián; Judit Bene; Katalin Komlósi; Ferenc Somogyvári; András Kondacs; Mihály Szabó; Lajos Fodor; Anita Bodor; Béla Melegh
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

2.  TNF-alpha and TNF-beta gene polymorphisms in cerebral infarction.

Authors:  Jae-Young Um; Neeon-Hyung An; Hyung-Min Kim
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

3.  The impact of detoxifying and repair gene polymorphisms on oxidative stress in ischemic stroke.

Authors:  Gürdal Orhan; Aylin Elkama; Semra Öztürk Mungan; Esra Eruyar; Bensu Karahalil
Journal:  Neurol Sci       Date:  2016-03-02       Impact factor: 3.307

4.  CYP1A1 and GSTM1/T1 genetic variation in predicting risk for cerebral infarction.

Authors:  Kyung-Suk Moon; Hye-Jung Lee; Seung-Heon Hong; Hyung-Min Kim; Jae-Young Um
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 2.866

5.  Genetics of ischaemic stroke among persons of non-European descent: a meta-analysis of eight genes involving approximately 32,500 individuals.

Authors:  Roshan Ariyaratnam; Juan P Casas; John Whittaker; Liam Smeeth; Aroon D Hingorani; Pankaj Sharma
Journal:  PLoS Med       Date:  2007-04       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.